Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Please read and follow all product warnings and directions
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 On February 27, 2026, HHS Secretary Kennedy announced that GHK-Cu is among approximately 14 peptides expected to return to Category 1
Potency Test This test measures the strength or concentration of an active pharmaceutical ingredient (API) over time, ensuring the medication maintains its potency until its beyond-use date when used with stability testing.
Collagen type I is particularly important because it forms the backbone of the extracellular matrix, supporting dermal strength and elasticity
US$ 24.13
US$ 20.93
US$ 28.78
US$ 20.10
US$ 25.13
US$ 28.69
US$ 28.06
